InvestorWire NewsRoom


Charting the Future of Biopharma and Medical Devices: DGE’s 2nd Chief Commercial Officer Summit Convenes Industry Leaders in Philadelphia
September 21, 2023

Charting the Future of Biopharma and Medical Devices: DGE’s 2nd Chief Commercial Officer Summit Convenes Industry Leaders in Philadelphia

DGE invites biotech, pharmaceutical and medical device leaders to attend the 2nd Chief Commercial Officer Summit to be held at The Bellevue Hotel, Philadelphia, PA, October 4-5, 2023. The much-awaited summit aims to chart the remarkable future of the biotech, pharmaceutical and medical device industries. The landmark event will feature a gathering of thought leaders and visionaries dedicated to driving commercial growth in the industry.

The role of Chief Commercial Officers (“CCOs”) has gained more significance with the progression of the life sciences landscape. The 2nd Chief Commercial Officer Summit provides a unique platform to explore key strategies for advancing commercial development, improving product value, and enhancing patient access. The summit explicitly caters to the challenges of the biopharma and medical device sectors, offering customized solutions and insights to the attendees.

Focused on Market Expansion and Patient Access

The 2nd Chief Commercial Officer Summit is committed to fostering brilliance in the biopharma and medical device industries. It’s an incredible platform to build connections, gain insights, and shape the future of commercial excellence. The summit provides attendees with a unique opportunity to explore the options to access new markets and territories, opening new possibilities for expansion and growth. The industry leaders will share their strategies to ensure the profitability and success of the biopharma and medical device products.

Who will attend:

  • Chief Commercial Officers
  • Commercialization Experts
  • Commercial Operations Professionals
  • Product Launch Leaders
  • Market Access Specialists
  • Digital Innovators
  • Reimbursement Specialists
  • Marketing Executives
  • Value Strategists
  • Pricing Experts
  • Gross-to-Net Analysts
  • Franchise Leaders
  • Branding Specialists
  • Sales Leaders
  • Finance Professionals
  • Business Development Executives
  • Licensing Specialists
  • Venture Capitalists
  • Distribution Channel Planners
  • Portfolio Managers

Interested participants should register for the event now.

To learn more, please visit

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).